Masimo Corporation
MASI
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Masimo Corporation vyvíjí, vyrábí a prodává neinvazivní monitorovací technologie a řešení pro automatizaci nemocnic po celém světě. Společnost nabízí technologii masimo Signální extrakce (SET) pulzní oximetrie s měřením průchozího pohybu a monitorováním nízké perfuzní pulzní oximetrie pro řešení primárních omezení konvenční pulzní oximetrie. Poskytuje také Masimo rainbow SET platformu, která zahrnuje duhový SET Pulse CO-Oximetry produkty, které neinvazivně monitorují hemoglobinové druhy, včetně nasycení kyslíkem, pulzní rychlosti, perfuzního indexu, indexu variability pleth a rychlosti dýchání z plethu; neinvazivně monitorují koncentraci hemoglobinu a karboxyhemoglobinu a methemoglobinu; monitorují arteriální nasycení kyslíkem a akustickou rychlost dýchání; a vypočítávají obsah kyslíku a index kyslíkových rezerv. Nabízí technologii SedLine pro monitorování funkce mozku pro měření elektrické aktivity mozku detekcí EEG signálů; produkty pro monitorování kapnografie a plynu zahrnující externí plug-in-and-measure capnografii a analyzátory plynu, integrované moduly, ruční kapnografové a kapnografické přístroje a odběrné linky pro měření kapnografie; O3 regionální oximetrii pro měření saturace tkáňovým kyslíkem; a hemodynamická monitorovací řešení. Jeho Masimo Hospital Automation platforma zahrnuje Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60 a MyView. Nabízí propojovací zařízení, a nosní ventilaci s vysokým průtokem a řešení neuromodulace. Své produkty poskytuje prostřednictvím přímého prodeje, distributorů a partnerů výrobců originálních zařízení nemocnicím, poskytovatelům zdravotnických služeb a domácí péče, zařízením dlouhodobé péče, lékařským ordinacím, veterinárním lékařům a spotřebitelům a výrobkům, které nejsou zdravotnickými ani spotřebitelskými, prostřednictvím internetových stránek elektronického obchodu masimopersonalhealth.com. Společnost byla založena v roce 1989 a sídlí v Irvine v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
3600
Založení
2007-08-08
Podobné společnosti
$ 11.44
- $ 0.11
$ 114.26
- $ 1.96
$ 17.74
- $ 0.27
$ 306.69
+ $ 1.13
$ 72.15
+ $ 0.25
$ 148.98
+ $ 6.16
$ 24.41
+ $ 0.31
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,526.9 | 1,526.9 | 2,094.4 | 2,048.1 | 2,035.8 | 1,239.2 | 1,143.7 | 937.8 | 858.3 | 798.1 | 694.6 | 630.1 | 586.6 | 547.2 | 493.2 | 439.0 | 405.4 | |
| Cost of Revenues | 581.7 | 581.7 | 1,090.0 | 1,044.6 | 977.0 | 430.8 | 400.7 | 308.7 | 283.4 | 263.0 | 230.8 | 220.1 | 195.9 | 188.4 | 167.0 | 144.9 | 119.8 | |
| Gross Profit | 945.2 | 945.2 | 1,004.4 | 1,003.5 | 1,058.8 | 808.3 | 743.1 | 629.2 | 574.9 | 535.1 | 463.8 | 410.0 | 390.8 | 358.8 | 326.3 | 294.1 | 285.6 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 412.5 | 371.5 | 370.9 | 372.0 | 600.7 | 504.6 | 343.9 | 339.6 | 548.9 | 478.9 | |
| Cost of Revenues | 165.2 | 140.9 | 137.6 | 138.0 | 356.0 | 241.4 | 136.6 | 133.0 | 286.2 | 244.1 | |
| Gross Profit | 247.3 | 230.6 | 233.3 | 234.0 | 244.7 | 263.2 | 207.3 | 206.6 | 262.7 | 234.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 175.2 | 191.4 | 137.2 | 118.7 | 93.3 | 77.0 | 62.0 | 59.4 | 56.6 | 56.6 | 55.6 | 47.1 | 38.4 | 36.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 664.0 | 657.4 | 395.3 | 369.1 | 314.7 | 289.5 | 275.8 | 253.7 | 252.7 | 241.0 | 215.5 | 193.9 | 169.2 | 143.4 | |
| Depreciation & Amortization | 38.8 | 38.8 | 103.0 | 98.3 | 136.1 | 35.6 | 28.4 | 23.5 | 21.1 | 20.1 | 16.8 | 15.7 | 12.8 | 11.4 | 9.4 | 7.3 | 6.6 | |
| Total Operating Expenses | 635.2 | 632.4 | 1,271.1 | 867.0 | 848.8 | 532.5 | 487.7 | 408.0 | 366.4 | 337.7 | 313.0 | 309.3 | 297.6 | 271.1 | 241.0 | 207.6 | 179.4 | |
| Operating Income | 310.0 | 312.8 | -266.7 | 136.5 | 210.0 | 275.8 | 255.8 | 221.2 | 208.0 | 197.4 | 420.8 | 120.3 | 103.5 | 79.7 | 85.2 | 86.5 | 104.9 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 38.0 | 46.5 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 159.8 | 156.1 | ||
| Depreciation & Amortization | 13.6 | 8.2 | 8.4 | 8.6 | 30.8 | 51.8 | 10.4 | 10.0 | 22.5 | 24.5 | ||
| Total Operating Expenses | 163.4 | 147.0 | 168.8 | 156.0 | 603.8 | 233.1 | 165.4 | 153.5 | 197.8 | 202.6 | ||
| Operating Income | 83.9 | 83.6 | 64.5 | 78.0 | -359.1 | 30.1 | 41.9 | 53.1 | 64.9 | 25.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.5 | 3.4 | 4.8 | 3.0 | 1.8 | 0.9 | 5.5 | 13.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 33.3 | 33.2 | 43.6 | 50.3 | 25.7 | 0.4 | 0.3 | 0.3 | -4.9 | -2.0 | -537.6 | -37.1 | -17.3 | 17.4 | 1.1 | 0.3 | -2.8 | |
| Other Expense | -37.3 | -40.2 | -38.6 | -48.4 | -16.6 | -1.4 | 7.9 | 13.0 | 5.3 | 2.0 | 267.6 | 15.7 | 8.9 | -12.0 | -1.4 | 0.0 | 1.3 | |
| IBT | 272.7 | 272.6 | -305.3 | 88.1 | 193.4 | 274.4 | 263.7 | 234.2 | 213.8 | 199.4 | 418.3 | 116.3 | 102.0 | 75.7 | 83.8 | 86.5 | 107.6 | |
| Income Tax Expense | 65.0 | 64.9 | -0.4 | 6.6 | 49.9 | 44.7 | 23.5 | 38.0 | 20.2 | 67.8 | 117.7 | 34.8 | 27.7 | 20.0 | 21.9 | 22.5 | 34.2 | |
| Net Income | -151.5 | -151.5 | -304.9 | 81.5 | 143.5 | 229.6 | 240.3 | 196.2 | 193.5 | 131.6 | 300.7 | 83.3 | 72.5 | 58.4 | 62.3 | 63.7 | 73.5 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.8 | 0.7 | 0.6 | 1.4 | 1.1 | 1.3 | 1.2 | 1.2 | 0.8 | 0.7 | ||
| Interest Expense | 7.5 | 8.8 | 8.2 | 8.8 | 10.0 | 10.5 | 11.0 | 12.0 | 13.8 | 12.8 | ||
| Other Expense | -9.9 | -8.7 | -9.1 | -9.6 | -2.6 | -18.5 | -11.1 | -11.6 | -20.9 | -11.2 | ||
| IBT | 74.0 | 74.9 | 55.4 | 68.4 | -361.7 | 11.6 | 30.8 | 41.5 | 23.2 | 14.0 | ||
| Income Tax Expense | 12.1 | 21.2 | 10.5 | 21.2 | -12.1 | 1.8 | 6.0 | 9.4 | -10.8 | 3.4 | ||
| Net Income | 68.3 | -100.4 | 51.3 | -170.7 | -349.6 | 9.8 | 16.0 | 18.9 | 33.9 | 10.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $1.54 | $2.68 | $4.16 | $4.39 | $3.67 | $3.70 | $2.42 | $6.28 | $1.62 | $1.33 | $1.03 | $1.08 | $1.07 | $1.25 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $1.51 | $2.60 | $3.98 | $4.14 | $3.44 | $3.45 | $2.23 | $5.85 | $1.55 | $1.30 | $1.02 | $1.07 | $1.05 | $1.21 | |
| Shares Outstanding | 53.6 | 53.6 | 53.3 | 52.8 | 53.6 | 55.2 | 54.7 | 53.4 | 52.3 | 51.5 | 49.5 | 51.3 | 54.7 | 56.7 | 57.4 | 59.7 | 58.8 | |
| Diluted Shares Outstanding | 54.2 | 54.2 | 53.3 | 54.1 | 55.2 | 57.7 | 58.0 | 57.1 | 56.0 | 55.9 | 53.2 | 53.7 | 55.6 | 57.5 | 58.4 | 60.8 | 60.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.64 | $0.20 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.63 | $0.20 | ||
| Shares Outstanding | 53.6 | 54.0 | 54.0 | 54.0 | 53.6 | 53.4 | 53.1 | 53.0 | 52.8 | 52.8 | ||
| Diluted Shares Outstanding | 54.2 | 54.4 | 54.8 | 54.8 | 53.6 | 54.3 | 54.3 | 54.2 | 53.7 | 53.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 132.4 | 177.6 | 163.0 | 202.9 | 745.3 | 641.4 | 567.7 | 552.5 | 315.3 | 306.0 | 132.3 | 134.5 | 95.5 | 71.6 | 129.9 | 88.3 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 120.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 132.4 | 177.6 | 163.0 | 202.9 | 745.3 | 641.4 | 687.7 | 552.5 | 315.3 | 306.0 | 132.3 | 134.5 | 95.5 | 71.6 | 129.9 | 88.3 | |
| Accounts Receivable | 406.1 | 489.3 | 421.0 | 445.9 | 200.8 | 141.4 | 132.4 | 109.6 | 121.3 | 101.7 | 81.0 | 78.6 | 84.1 | 75.0 | 64.1 | 61.7 | |
| Inventory | 513.0 | 459.2 | 545.0 | 501.0 | 201.4 | 216.0 | 115.9 | 93.8 | 95.9 | 72.5 | 62.0 | 69.7 | 56.8 | 47.4 | 45.9 | 45.0 | |
| Other Current Assets | 90.7 | 99.7 | 102.9 | 158.8 | 91.0 | 102.4 | 60.1 | 29.2 | 28.1 | 26.0 | 21.4 | 4.1 | 2.8 | 3.9 | 2.0 | 2.1 | |
| Total Current Assets | 1,142.2 | 1,225.8 | 1,231.9 | 1,308.6 | 1,238.4 | 1,101.2 | 996.1 | 785.1 | 564.1 | 507.2 | 299.1 | 315.1 | 271.8 | 219.3 | 262.9 | 217.6 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 314.7 | 149.6 | 130.8 | 177.6 | 158.5 | 129.6 | 149.5 | 166.0 | 124.4 | 150.7 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 314.7 | 149.6 | 130.8 | 177.6 | 158.5 | 129.6 | 149.5 | 166.0 | 124.4 | 150.7 | |
| Accounts Receivable | 355.9 | 352.5 | 346.6 | 489.3 | 444.6 | 406.1 | 401.0 | 421.0 | 420.5 | 408.8 | |
| Inventory | 338.6 | 318.5 | 301.2 | 459.2 | 569.9 | 513.0 | 506.1 | 545.0 | 584.6 | 542.6 | |
| Other Current Assets | 39.1 | 449.2 | 405.4 | 99.7 | 106.9 | 93.5 | 109.0 | 102.9 | 108.0 | 106.1 | |
| Total Current Assets | 1,048.3 | 1,269.8 | 1,184.0 | 1,225.8 | 1,279.9 | 1,142.2 | 1,165.6 | 1,231.9 | 1,237.5 | 1,208.2 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 491.4 | 456.0 | 483.5 | 402.5 | 272.8 | 272.5 | 219.6 | 166.0 | 164.1 | 136.0 | 132.5 | 102.0 | 24.9 | 23.9 | 15.2 | 16.0 | |
| Goodwill | 389.0 | 96.7 | 407.7 | 445.4 | 100.3 | 103.2 | 22.4 | 23.3 | 20.6 | 19.8 | 20.4 | 21.0 | 22.8 | 22.8 | 0.4 | 0.4 | |
| Intangible Assets | 606.1 | 558.2 | 652.3 | 722.6 | 72.5 | 73.9 | 27.3 | 27.9 | 27.1 | 29.4 | 27.6 | 27.8 | 28.1 | 27.4 | 11.4 | 10.5 | |
| Long-Term Investments | 112.2 | 8.6 | 111.9 | 13.8 | 13.8 | 8.0 | 6.5 | 1.2 | 1.2 | 79.9 | 66.8 | 67.5 | 61.7 | 52.1 | 51.7 | 47.2 | |
| Other Long-Term Assets | 46.0 | 136.8 | 47.0 | 215.2 | 136.5 | 114.4 | 88.5 | 130.1 | 109.1 | 9.2 | 11.0 | 7.5 | 6.8 | 8.0 | 7.6 | 6.0 | |
| Total Long-Term Assets | 1,751.7 | 1,399.9 | 1,809.6 | 1,902.0 | 648.6 | 611.4 | 400.1 | 369.7 | 346.1 | 313.3 | 302.6 | 249.9 | 166.9 | 156.6 | 103.2 | 92.6 | |
| Total Assets | 2,893.9 | 2,625.7 | 3,041.5 | 3,210.6 | 1,887.0 | 1,712.6 | 1,396.1 | 1,154.8 | 910.2 | 820.5 | 601.7 | 565.0 | 438.7 | 375.9 | 366.1 | 310.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 345.3 | 364.1 | 359.8 | 456.0 | 501.0 | 490.0 | 490.1 | 485.0 | 415.0 | 410.0 | |
| Goodwill | 100.8 | 100.9 | 98.3 | 96.7 | 412.5 | 389.0 | 396.0 | 407.7 | 400.1 | 410.9 | |
| Intangible Assets | 56.7 | 116.4 | 60.5 | 558.2 | 640.8 | 606.1 | 635.9 | 1,204.6 | 630.0 | 665.7 | |
| Long-Term Investments | 48.5 | 8.0 | 7.9 | 8.6 | 9.4 | 9.2 | 9.5 | 111.9 | 124.6 | 13.9 | |
| Other Long-Term Assets | 98.6 | 482.8 | 462.9 | 136.8 | 137.1 | 150.4 | 153.5 | -506.8 | 100.5 | 214.1 | |
| Total Long-Term Assets | 769.2 | 1,191.5 | 1,108.6 | 1,399.9 | 1,807.9 | 1,751.7 | 1,792.1 | 1,809.6 | 1,758.4 | 1,803.0 | |
| Total Assets | 1,817.5 | 2,402.6 | 2,293.1 | 2,625.7 | 3,087.8 | 2,893.9 | 2,957.7 | 3,041.5 | 2,995.9 | 3,011.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 216.0 | 252.8 | 251.5 | 276.8 | 75.6 | 64.1 | 54.5 | 40.4 | 33.8 | 31.1 | 25.9 | 38.0 | 28.0 | 27.0 | 27.3 | 22.2 | |
| Short-Term Debt | 55.2 | 58.7 | 70.7 | 33.8 | 6.4 | 6.0 | 4.7 | 49.5 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Other Current Liabilities | 237.5 | 203.9 | 188.1 | 238.8 | 134.9 | 118.9 | 87.1 | 24.6 | 81.9 | 151.0 | 85.4 | 64.7 | 54.9 | 43.2 | 32.6 | 31.6 | |
| Current Liabilities | 546.2 | 617.7 | 563.8 | 630.0 | 267.7 | 233.8 | 172.2 | 147.6 | 151.6 | 220.4 | 132.6 | 123.9 | 103.8 | 89.5 | 76.0 | 70.2 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 117.9 | 135.7 | 124.9 | 252.8 | 280.8 | 216.0 | 203.1 | 251.5 | 283.5 | 265.5 | |
| Short-Term Debt | 7.7 | 22.9 | 23.8 | 58.7 | 61.9 | 55.2 | 53.9 | 70.7 | 46.3 | 49.5 | |
| Other Current Liabilities | 206.1 | 357.0 | 324.8 | 203.9 | 199.5 | 189.9 | 161.5 | 188.1 | 192.6 | 189.0 | |
| Current Liabilities | 369.7 | 592.1 | 546.5 | 617.7 | 637.6 | 546.2 | 504.2 | 563.8 | 578.8 | 571.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 746.5 | 787.4 | 917.5 | 941.6 | 26.3 | 28.4 | 15.8 | 69.9 | -9.9 | -0.3 | 185.1 | 125.9 | 0.2 | 2.0 | 0.1 | 0.1 | |
| Capital Leases | 61.7 | 80.9 | 64.0 | 72.1 | 32.7 | 34.3 | 20.5 | 0.0 | 0.0 | 0.1 | 0.1 | 1.0 | 0.3 | 2.1 | 0.1 | 0.2 | |
| Def. Tax Liability | 130.9 | 100.1 | 136.1 | 163.6 | 5.1 | 6.2 | 3.1 | 3.0 | 9.9 | 0.3 | 0.2 | 24.2 | 0.0 | 8.1 | 0.0 | 0.0 | |
| Total Liabilities | 1,525.1 | 1,573.8 | 1,676.7 | 1,871.7 | 336.8 | 304.9 | 228.3 | 185.8 | 203.3 | 260.3 | 326.0 | 257.3 | 112.3 | 100.3 | 86.4 | 80.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 578.5 | 619.3 | 657.7 | 787.4 | 799.0 | 808.2 | 902.9 | 917.5 | 953.1 | 935.9 | |
| Capital Leases | 0.0 | 28.5 | 30.5 | 80.9 | 88.3 | 61.7 | 80.8 | 45.8 | 60.0 | 64.8 | |
| Def. Tax Liability | 29.6 | 0.2 | 0.2 | 100.1 | 111.3 | 102.1 | 106.9 | 136.1 | 112.1 | 118.9 | |
| Total Liabilities | 1,007.5 | 1,359.8 | 1,346.7 | 1,573.8 | 1,624.6 | 1,525.1 | 1,592.5 | 1,676.7 | 1,720.3 | 1,702.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | 1,830.7 | 1,490.9 | 1,795.8 | 1,714.3 | 1,570.9 | 1,341.2 | 1,100.5 | 931.1 | 720.8 | 589.2 | 288.6 | 205.3 | 132.7 | 74.4 | 69.4 | 5.7 | |
| Comprehensive Income | -103.4 | -108.2 | -45.3 | 11.5 | -5.5 | 1.4 | -6.7 | -6.2 | -2.9 | -7.0 | -4.7 | -2.1 | 4.0 | 3.5 | 1.3 | 0.9 | |
| Total Common Equity | 1,368.8 | 1,051.9 | 1,364.8 | 1,338.9 | 1,550.2 | 1,407.7 | 1,167.9 | 969.1 | 706.9 | 560.2 | 275.4 | 306.0 | 326.5 | 273.1 | 276.8 | 227.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | 1,271.1 | 1,371.5 | 1,320.2 | 1,490.9 | 1,840.5 | 1,830.7 | 1,814.7 | 1,795.8 | 1,761.9 | 1,751.3 | |
| Comprehensive Income | -13.4 | -49.0 | -86.1 | -108.2 | -36.6 | -103.4 | -75.3 | -45.3 | -90.9 | -47.6 | |
| Total Common Equity | 810.0 | 1,042.8 | 946.4 | 1,051.9 | 1,463.2 | 1,368.8 | 1,365.2 | 1,364.8 | 1,275.6 | 1,308.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 863.4 | 846.1 | 970.0 | 975.4 | 32.7 | 34.3 | 20.5 | 0.0 | 0.0 | 0.1 | 185.1 | 126.0 | 0.3 | 2.1 | 0.1 | 0.2 | |
| Book Value | 1,368.8 | 1,051.9 | 1,364.8 | 1,338.9 | 1,550.2 | 1,407.6 | 1,167.9 | 969.1 | 706.9 | 560.2 | 275.7 | 307.7 | 326.4 | 275.7 | 279.7 | 230.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 810.0 | 1,042.8 | 946.4 | 1,051.9 | 1,463.2 | 1,368.8 | 1,365.2 | 1,364.8 | 1,275.6 | 1,308.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 79.5 | -151.5 | -304.9 | 81.5 | 143.5 | 229.6 | 240.3 | 196.2 | 193.5 | 131.6 | 300.7 | 81.5 | 74.4 | 55.7 | 61.9 | 64.1 | 73.4 | |
| Depreciation & Amortization | 95.2 | 38.8 | 103.0 | 98.3 | 136.1 | 35.6 | 29.3 | 23.5 | 21.1 | 20.1 | 16.8 | 15.7 | 12.8 | 11.4 | 9.4 | 7.3 | 6.6 | |
| Stock-Based Compensation | 31.4 | 35.8 | 41.5 | 7.0 | 47.7 | 44.6 | 42.2 | 39.2 | 27.4 | 17.2 | 12.5 | 10.8 | 11.0 | 11.7 | 14.1 | 13.7 | 12.3 | |
| Change Working Capital | 6.3 | -89.9 | -10.7 | -70.9 | -261.8 | -31.3 | -96.5 | -32.4 | 7.2 | -146.0 | 80.8 | 8.2 | -4.0 | -18.9 | -7.4 | -9.4 | -36.3 | |
| Change In Accounts Receivable | 20.1 | 17.2 | -60.2 | 91.9 | -138.5 | -60.8 | -2.2 | -23.6 | 10.8 | -19.8 | -21.2 | -9.9 | 4.9 | -9.6 | -10.1 | -7.5 | -10.9 | |
| Change In Accounts Payable | -30.3 | -27.1 | 14.8 | -19.6 | 60.5 | 11.0 | 7.6 | 9.9 | 5.2 | -4.1 | 7.8 | -4.3 | -1.4 | 1.0 | -1.7 | 5.2 | 5.5 | |
| Change In Inventories | -16.1 | -112.1 | -7.5 | -69.2 | -155.9 | 13.5 | -94.4 | -21.3 | -1.9 | -22.9 | -10.8 | 7.5 | -13.4 | -9.5 | -0.5 | -3.0 | -14.1 | |
| Other Non-cash Items | 69.9 | 372.2 | 405.7 | 13.8 | 3.3 | 1.3 | 0.6 | 1.0 | -1.5 | 11.3 | 0.6 | -2.1 | 1.3 | 2.3 | 3.9 | 4.9 | 7.2 | |
| Cash from Operations | 190.4 | 0.0 | 0.0 | 94.1 | 29.5 | 264.8 | 211.0 | 221.6 | 239.5 | 58.1 | 416.8 | 114.2 | 95.5 | 54.3 | 75.4 | 79.0 | 61.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 497.7 | 53.7 | 44.9 | 47.2 | -349.6 | -12.2 | 24.8 | 32.1 | 34.0 | 10.6 | |
| Depreciation & Amortization | 13.6 | 8.1 | 8.4 | 8.6 | 30.8 | 51.8 | 10.4 | 10.0 | 22.5 | 24.5 | |
| Stock-Based Compensation | 8.9 | 0.0 | 8.5 | 9.1 | 11.9 | 9.0 | 11.9 | 8.7 | 9.4 | -1.1 | |
| Change Working Capital | -31.7 | -18.5 | -6.1 | -33.6 | -8.1 | -9.1 | 19.3 | -12.8 | 43.2 | -49.7 | |
| Change In Accounts Receivable | 18.4 | 6.7 | -3.9 | -4.0 | -57.9 | 5.6 | 6.0 | -13.9 | 13.9 | -11.1 | |
| Change In Accounts Payable | -13.5 | -16.3 | 8.8 | -6.1 | -14.6 | 46.0 | -8.8 | -7.8 | -23.2 | 15.4 | |
| Change In Inventories | -49.4 | -31.0 | -25.1 | -6.6 | 32.6 | -35.4 | -7.5 | 2.8 | 23.9 | -47.6 | |
| Other Non-cash Items | -433.9 | 13.5 | 13.7 | -6.1 | 365.5 | -13.9 | 8.1 | 7.8 | 3.6 | 0.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 77.1 | -7.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -79.3 | -19.4 | -20.0 | -44.0 | -56.3 | -34.9 | -80.0 | -72.5 | -22.7 | -46.8 | -24.4 | -54.6 | -78.4 | -13.0 | -14.5 | -7.5 | -11.5 | |
| Acquisitions | 18.3 | 0.0 | 0.0 | 7.5 | -999.7 | 0.0 | -116.1 | 0.0 | -3.9 | 0.0 | -0.8 | 0.0 | 0.0 | 0.0 | -37.4 | 0.0 | 1.9 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.4 | -125.2 | 0.0 | -1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -76.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 120.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 133.0 | |
| Other Investing Activities | -2.6 | 0.0 | 0.0 | -44.7 | -1.6 | -2.6 | 0.7 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.9 | |
| Cash from Investing | -68.9 | 0.0 | 0.0 | -81.2 | -1,057.6 | -37.5 | -82.8 | -197.7 | -26.2 | -47.9 | -25.1 | -54.6 | -78.4 | -13.0 | -51.9 | -7.5 | 45.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -7.1 | -7.1 | -3.8 | -2.6 | 4.5 | -14.8 | -3.6 | -6.1 | -25.3 | -22.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.5 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.5 | -0.3 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -25.3 | -22.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -199.9 | 0.0 | 0.0 | -51.2 | -135.4 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -230.1 | -70.1 | -0.1 | -0.1 | 0.0 | -0.1 | -0.1 | |
| Debt Issued | 174.5 | 846.1 | -123.9 | 45.8 | 1,078.1 | -1.7 | 13.9 | 20.5 | 0.0 | 0.0 | 45.0 | 129.3 | 125.7 | -1.6 | 2.0 | 0.0 | 0.2 | |
| Issuance of Common Stock | 10.9 | 0.0 | 0.0 | 7.0 | 8.1 | 23.2 | 58.4 | 28.3 | 44.7 | 62.2 | 37.3 | 28.3 | 4.7 | 3.3 | 1.6 | 5.9 | 10.2 | |
| Repurchase of Common Stock | -6.0 | -363.7 | 0.0 | 0.0 | -401.5 | -128.9 | -110.5 | -37.6 | -18.5 | -66.3 | -68.2 | -150.2 | -102.5 | -19.8 | -26.3 | -36.2 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -45.0 | -130.0 | -125.0 | 0.0 | -57.3 | 0.0 | -162.0 | |
| Other Financing Activities | 54.5 | 0.0 | 0.0 | -12.9 | 1,049.1 | -16.7 | -2.2 | -0.1 | -0.5 | 0.1 | 89.4 | 262.9 | 249.1 | -1.3 | -0.2 | 0.1 | 0.7 | |
| Cash from Financing | -134.5 | 0.0 | 0.0 | -57.1 | 520.3 | -122.4 | -54.3 | -9.3 | 25.8 | -4.1 | -216.6 | -59.1 | 26.2 | -17.9 | -82.1 | -30.2 | -151.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -36.4 | 18.6 | |
| Debt Issued | 586.2 | -56.0 | -39.3 | -164.6 | -14.8 | -2.5 | -93.4 | -13.2 | 96.3 | 39.9 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.7 | |
| Repurchase of Common Stock | -186.7 | -163.3 | -13.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -36.3 | 19.3 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -19.5 | 26.0 | 13.2 | -41.4 | -538.8 | 103.4 | 76.9 | 15.4 | 237.2 | 7.3 | 173.7 | -2.1 | 39.0 | 23.9 | -58.3 | 41.6 | -43.7 | |
| Closing Cash Balance | 132.4 | 152.3 | 181.4 | 168.2 | 209.6 | 748.4 | 645.0 | 568.1 | 552.6 | 315.5 | 306.0 | 132.3 | 134.5 | 95.5 | 71.6 | 129.9 | 88.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -162.4 | 162.4 | 20.6 | -4.9 | 17.7 | 28.1 | -28.4 | -4.2 | 39.2 | -26.3 | |
| Closing Cash Balance | 152.3 | 314.7 | 197.1 | 176.5 | 181.4 | 163.7 | 135.6 | 164.0 | 166.0 | 132.3 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 111.1 | 197.8 | 145.3 | 6.4 | -26.8 | 229.8 | 131.0 | 149.1 | 216.8 | 11.3 | 392.5 | 59.6 | 17.0 | 41.3 | 60.9 | 71.4 | 49.5 | |
| Real Free Cash Flow | 79.7 | 162.0 | 103.8 | -0.6 | -74.5 | 185.2 | 88.8 | 109.9 | 189.4 | -5.8 | 380.0 | 48.8 | 6.0 | 29.6 | 46.8 | 57.8 | 37.2 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 53.4 | 50.9 | 64.5 | 27.0 | 47.5 | -4.7 | 67.4 | 35.1 | 51.8 | -29.1 | |
| Real Free Cash Flow | 44.5 | 50.9 | 56.0 | 17.9 | 35.6 | -13.7 | 55.5 | 26.4 | 42.4 | -28.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -12.7 | 35.5 | 1703.4 |
| P/S | 4.2 | 5.9 | 67.9 |
| P/B | 8.9 | 7 | 25.8 |
| P/FCF | 45.1 | 42.1 | 396.3 |
| Market cap | $7.8 | $6.9 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 32.3 % | 11.3 % | 0 % |
| Debt to Income | -386.9 % | 165.5 % | 0 % |
| Debt to Free cash flow | 346.2 % | 14843.4 % | 0 % |
| Interest expense percentage | 10.7 % | -4.2 % | 38.7 % |
| Current ratio | 2.8 | 3.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -18.7 % | 16.5 % | 0 % |
| ROA | -8.3 % | 12.2 % | 0 % |
| CapEx to Revenue | 0.5 % | 4.6 % | 10.6 % |
| RaD to Revenue | 0 % | 9.3 % | 0 % |
| ROEM | 424,138.9 | 222839.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 55 % | 63.3 % | 79.8 % |
| Operating margin | -7.8 % | 19.7 % | 29.6 % |
| Net margin | -33.2 % | 14 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1.8 % | 0 % |
| Dividend payout percentage | 0 % | 49.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 54.4 mil | 56.4 mil |
| Employee count | 3.6 tis | 1.9 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
